Death-inducer obliterator 1
Death-inducer obliterator 1 (941-951) is a synthetic peptide fragment corresponding to amino acid residues 941 to 951 of the Death-inducer obliterator 1 (DIO-1) protein. As a bioactive peptide, it represents a highly specific region within the DIO-1 sequence, which is implicated in the regulation of programmed cell death and intracellular signaling pathways. The fragment's defined sequence enables targeted investigation of protein-protein interactions, post-translational modifications, and functional domains associated with apoptotic mechanisms. Its availability as a research-grade peptide offers an invaluable tool for dissecting the molecular underpinnings of cell death and related cellular processes, providing a foundation for advancing both basic and applied biochemical research.
Peptide functional studies: Researchers utilize the DIO-1 (941-951) peptide to investigate the role of discrete protein regions in modulating apoptosis and cell fate decisions. By introducing this peptide into cellular or in vitro systems, scientists can probe its ability to interact with endogenous binding partners, disrupt or mimic native protein functions, and delineate critical residues essential for activity. Such experiments are instrumental in mapping functional domains within the parent protein and in elucidating the molecular determinants of death-inducing signaling cascades.
Protein-protein interaction analysis: The defined sequence of this peptide fragment allows for targeted studies of intermolecular binding events. It serves as a tool for affinity-based assays, such as pull-down experiments or surface plasmon resonance, to identify and characterize proteins or biomolecules that specifically recognize the DIO-1 (941-951) region. These applications facilitate the identification of novel interaction partners, enabling researchers to reconstruct elements of the DIO-1 interactome and to understand how specific motifs contribute to complex assembly and signal transduction.
Antibody epitope mapping: The DIO-1 (941-951) peptide acts as a valuable antigenic determinant for generating and validating antibodies against the parent protein. By employing this defined fragment in immunoassays, researchers can assess antibody specificity, map epitope boundaries, and develop reagents for sensitive detection of DIO-1. This approach is essential for the production of high-affinity, sequence-specific antibodies, which are critical tools for immunoblotting, immunoprecipitation, and immunohistochemistry applications.
Post-translational modification studies: The peptide's sequence can be chemically modified to mimic or introduce post-translational modifications, such as phosphorylation, acetylation, or ubiquitination, at specific residues. Such modified peptides serve as standards or probes in mass spectrometry-based analyses, enabling the study of modification-dependent changes in protein function, recognition, or degradation. These investigations are pivotal for understanding how dynamic modifications within the DIO-1 (941-951) region influence cellular signaling networks and regulatory mechanisms.
Peptide synthesis and assay development: As a well-defined sequence, DIO-1 (941-951) is routinely used as a reference standard and positive control in peptide synthesis validation and biochemical assay optimization. Its physicochemical properties and established sequence make it suitable for calibrating analytical techniques, such as HPLC or mass spectrometry, and for benchmarking the performance of novel assay formats. Incorporating this peptide into experimental workflows supports reliable, reproducible peptide-based research and enhances the development of robust analytical methodologies.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More